In Brazil 45% of patients affected with Panic attacks and Panic disorder. In 2014, number of patients with Panic attacks and Panic disorder were 40% among total population. In terms of medications, specific members of the selective serotonin reuptake inhibitor (SSRI), the selective serotonin and norepinephrine reuptake inhibitors (SSNRI), and the benzodiazepine families of medications are approved by the U.S. Food and Drug Administration (FDA) for effective treatment of panic disorder.
Most people who struggle with panic want very much to know what causes panic attacks. Although there are not specific causes for panic attacks in adults, teens, or children, like most other emotional symptoms, panic is understood to be the result of a combination of biological vulnerabilities, ways of thinking, and environmental factors like social stressors.